查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
北美 dPCR 和 qPCR 市場預測至 2030 年 - 區域分析 - 按治療、產品、應用和最終用戶
市場調查報告書
商品編碼
1494308

北美 dPCR 和 qPCR 市場預測至 2030 年 - 區域分析 - 按治療、產品、應用和最終用戶

North America dPCR and qPCR Market Forecast to 2030 - Regional Analysis - By Treatment, Product, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 97 Pages | 訂單完成後即時交付

價格

2022年北美dPCR和qPCR市場估值為35.5108億美元，預計2030年將達到74.2903億美元；預計 2022 年至 2030 年複合年成長率為 9.7%。

遺傳性疾病和傳染病發病率的增加推動北美 dPCR 和 qPCR 市場

根據國家組織關於遺傳性疾病或先天性殘疾的資訊，雖然個體遺傳性疾病很少見，但總體而言，被診斷患有遺傳性疾病的人超過 15,500 人。美國 MJH 生命科學公司的報告估計，到 2022 年，全球每年有 30 萬名新生兒患有鐮狀細胞疾病，佔 ?佔全球人口的5%。在美國，它是最常見的遺傳疾病之一。此外，每 500 名非裔美國人中就有 1 人患有鐮狀細胞疾病，且？據美國疾病管制與預防中心 (CDC) 稱，其中 12 人中有 1 人患有常染色體隱性突變。 COVID-19 的爆發對聚合酶鍊式反應市場的成長產生了重大影響。臨床診斷市場不斷成長的需求對PCR產業產生了有利的影響。幾乎所有診斷測試都使用 RT-PCR 來測試有 COVID-19 症狀的人，並且醫療保健專家敦促他們進行診斷測試，而當局尚未認可病毒培養測試。大多數生物技術和製藥企業都將精力集中在研發部門，尋找針對 COVID-19 的新化合物或治療方法。 2022年2月，羅氏將新發表的分子實驗室儀器Cobas 5800系統加入其COVID-19 PCR產品組合中，供接受CE認證的國家使用。這些產品包括cobas SARS-CoV-2和甲型/乙型流感檢測，以及cobas SARS-CoV-2定性檢測。透過在低、中和高容量分子實驗室測試需求中提供統一的性能和效率，這些產品拓寬了羅氏診斷的分子產品組合。此外，借助新型緊湊型 Cobas 5800 系統，空間或資源有限的醫療保健組織可以進行全面存取。在由於缺乏資源或空間而無法容納較大設備的國家或地區，這將帶來更好的測試可訪問性。

因此，可使用 dPCR 和 qPCR 技術進行診斷和治療的遺傳性疾病和傳染病的發生率不斷增加，支持了北美 dPCR 和 qPCR 市場的成長。

北美 dPCR 和 qPCR 市場概覽

北美 dPCR 和 qPCR 市場分為美國、加拿大和墨西哥。北美是最大的生物技術市場，其中美國佔最大的市場佔有率，其次是加拿大。北美市場的成長歸因於生物分析儀器製造商和 PCR 公司對創新產品的需求增加、主要市場參與者的存在以及各個學術和研究機構進行的廣泛研發。醫療保健領域對先進方法整合的日益關注、政府和私人促進精準醫療的舉措，以及政府和私人機構為基因組研究提供的大量資金，預計也將刺激北美 dPCR 和 qPCR 的成長並創造非凡的收入北美市場。此外，該國各研究小組的科學進展與該地區在全球市場定位中的成長和主導地位相對應。

北美 dPCR 和 qPCR 市場收入及 2030 年預測（百萬美元）

北美 dPCR 和 qPCR 市場細分

北美 dPCR 和 qPCR 市場根據治療、產品、應用、最終用戶和國家進行細分。

根據處理方式，北美 dPCR 和 qPCR 市場分為定量 PCR (qPCR) 和數位 PCR (dPCR)。到 2022 年，數位 PCR (dPCR) 領域將佔據更大的佔有率。

按產品分類，北美 dPCR 和 qPCR 市場分為試劑和耗材、儀器以及軟體和服務。 2022 年，試劑和耗材領域佔最大佔有率。

依應用分類，北美 dPCR 和 qPCR 市場分為研究應用、臨床應用和法醫應用。 2022年，臨床應用領域佔據最大佔有率。

按最終用戶分類，北美 dPCR 和 qPCR 市場分為醫院和診斷中心、製藥和生物技術公司、研究實驗室和學術機構、法醫實驗室和臨床研究組織。 2022 年，醫院和診斷中心細分市場佔據最大佔有率。

根據國家/地區，北美 dPCR 和 qPCR 市場分為美國、加拿大和墨西哥。 2022 年，美國主導北美 dPCR 和 qPCR 市場。

Abbott Laboratories、Thermo Fisher Scientific Inc、Takara Bio Inc、Qiagen NV、Standard BioTools Inc、樂普醫療科技北京有限公司、F. Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc 和 Agilent Technologies Inc 是一些領先公司營運北美dPCR 和qPCR 市場。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：北美 dPCR 和 qPCR 市場 - 主要產業動態

  • 市場促進因素
    • 遺傳性疾病和傳染病的發生率不斷增加
    • 基因合成的投資和資金不斷增加
    • PCR 技術的技術進步
  • 市場限制
    • PCR 系統成本高
    • 與 qPCR 相關的技術限制
  • 市場機會
    • 新興國家擴大採用 PCR 方法
  • 未來的趨勢
    • 微滴式數位PCR的發展
  • 影響分析：

第 5 章：dPCR 和 qPCR 市場 - 北美市場分析

  • 北美 dPCR 和 qPCR 市場收入，2022 - 2030

第 6 章：北美 dPCR 和 qPCR 市場 - 收入和 2030 年預測 - 按治療方式

  • 概述
  • 2022 年和 2030 年北美 dPCR 和 qPCR 市場收入佔有率（按治療方式）（%）
  • 定量PCR
  • 數位PCR

第 7 章：北美 dPCR 和 qPCR 市場 - 收入和 2030 年預測 - 按產品

  • 概述
  • 北美 dPCR 和 qPCR 市場收入佔有率（按產品），2022 年和 2030 年 (%)
  • 試劑及耗材
  • 儀器
  • 軟體與服務

第 8 章：北美 dPCR 和 qPCR 市場 - 收入和 2030 年預測 - 按應用

  • 概述
  • 2022 年和 2030 年北美 dPCR 和 qPCR 市場收入佔有率（按應用分類）（%）
  • 研究應用
  • 臨床應用
  • 法醫應用

第 9 章：北美 dPCR 和 qPCR 市場 - 收入和 2030 年預測 - 按最終用戶

  • 概述
  • 2022 年和 2030 年北美 dPCR 和 qPCR 市場收入佔有率（按最終用戶分類）（%）
  • 醫院和診斷中心
  • 製藥和生物技術公司
  • 研究實驗室和學術機構
  • 法醫實驗室
  • 臨床研究組織

第 10 章：北美 dPCR 和 qPCR 市場 - 國家分析

    • 北美 dPCR 和 qPCR 市場（按國家）
      • 美國
      • 加拿大
      • 墨西哥

第 11 章：dPCR 和 qPCR 市場-產業格局

  • 概述
  • 北美 dPCR 和 qPCR 市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 12 章：公司簡介

  • Abbott Laboratories
  • Thermo Fisher Scientific Inc
  • Takara Bio Inc
  • Qiagen NV
  • Standard BioTools Inc
  • Lepu Medical Technology Beijing Co Ltd
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Agilent Technologies Inc

第 13 章：附錄

Product Code: BMIRE00029878

The North America dPCR and qPCR market was valued at US$ 3,551.08 million in 2022 and is expected to reach US$ 7,429.03 million by 2030; it is estimated to grow at a CAGR of 9.7% from 2022 to 2030.

Increasing Incidence of Genetic and Infectious Diseases Drive North America dPCR and qPCR Market

According to the National Organization's information on genetic conditions or congenital disabilities, though individual genetic disorders are rare, collectively, they comprise over 15,500 people diagnosed with genetic disorders. In 2022, a report by MJH Life Sciences (US) estimates that 300,000 newborns worldwide are born with sickle cell disease every year, accounting for ? 5% of the global population. In the US, it is one of the most prevalent genetic conditions. Also, 1 in 500 African Americans is affected by sickle cell disease, and ? 1 in 12 of them suffers from the autosomal recessive mutation, according to the CDC. The COVID-19 outbreak had a significant effect on the polymerase chain reaction market growth. The growing demand in the clinical diagnostic market has a favorable effect on the PCR industry. Nearly all diagnostic tests use RT-PCR to test the people having symptoms of COVID-19 and were urged by healthcare experts to undergo a diagnostic test, while the authorities have not endorsed viral culture tests. The majority of biotech and pharmaceutical businesses were concentrating their efforts on research and development divisions to find novel compounds or therapy approaches for COVID-19. In February 2022, Roche added the Cobas 5800 System, a newly released molecular laboratory instrument, to its COVID-19 PCR portfolio for use in nations that accept the CE certification. These product include the cobas SARS-CoV-2 and influenza A/B tests, as well as the cobas SARS-CoV-2 qualitative test. By offering uniform performance and efficiency across low-, medium-, and high-volume molecular laboratory testing needs, these products broaden the Roche Diagnostics molecular portfolio offering. Additionally, healthcare organizations with limited space or resources can have comprehensive access owing to the new, compact Cobas 5800 System. Better testing accessibility will result from this in nations or settings where larger equipment cannot be accommodated due to a lack of resources or space.

Thus, increasing incidence of genetic and infectious diseases in which dPCR and qPCR techniques can be used for diagnosis and treatments support the growth of the North America dPCR and qPCR market.

North America dPCR and qPCR Market Overview

The North America dPCR and qPCR market in North America is segmented into the US, Canada, and Mexico. North America is the largest market for biotechnology, with the US holding the largest market share, followed by Canada. The market growth in North America is attributed to an increase in the demand for innovative products from bio-analytical instrument manufacturers and PCR companies, the presence of key market players, and extensive R&D conducted across various academic and research institutes. The increasing focus on advanced method incorporation in healthcare, government and private initiatives for promoting precision medicine, and massive funds from government and private bodies for genomic research are also expected to stimulate the growth and contribute to exceptional revenue generation for the North America dPCR and qPCR market in North America. Additionally, scientific advances made by various research groups in the country correspond to the growth and dominance of the region in the global market positioning.

North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Million)

North America dPCR and qPCR Market Segmentation

The North America dPCR and qPCR market is segmented based on treatment, product, application, end user, and country.

Based on treatment, the North America dPCR and qPCR market is bifurcated into quantitative PCR (qPCR) and digital PCR (dPCR). The digital PCR (dPCR) segment held a larger share in 2022.

By product, the North America dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share in 2022.

By application, the North America dPCR and qPCR market is segmented into research application, clinical application, and forensic application. The clinical application segment held the largest share in 2022. The clinical application segment is further subsegmented into oncology testing, blood screening, infectious disease testing, and other applications.

By end user, the North America dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held the largest share in 2022.

Based on country, the North America dPCR and qPCR market is segmented into segmented into the US, Canada, and Mexico. The US dominated the North America dPCR and qPCR market in 2022.

Abbott Laboratories, Thermo Fisher Scientific Inc, Takara Bio Inc, Qiagen NV, Standard BioTools Inc, Lepu Medical Technology Beijing Co Ltd, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, and Agilent Technologies Inc are some of the leading companies operating in the North America dPCR and qPCR market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America dPCR and qPCR Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Incidence of Genetic and Infectious Diseases
    • 4.1.2 Rising Investments and Funds for Gene Synthesis
    • 4.1.3 Technological Advancements in PCR Technologies
  • 4.2 Market Restraints
    • 4.2.1 High Costs of PCR Systems
    • 4.2.2 Technical Limitations Associated with qPCR
  • 4.3 Market Opportunities
    • 4.3.1 Growing Adoption of PCR Methods in Emerging Countries
  • 4.4 Future Trends
    • 4.4.1 Development of Droplet Digital PCR
  • 4.5 Impact Analysis:

5. dPCR and qPCR Market - North America Market Analysis

  • 5.1 North America dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030

6. North America dPCR and qPCR Market - Revenue and Forecast to 2030 - by Treatment

  • 6.1 Overview
  • 6.2 North America dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • 6.3 Quantitative PCR
    • 6.3.1 Overview
    • 6.3.2 Quantitative PCR: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Digital PCR
    • 6.4.1 Overview
    • 6.4.2 Digital PCR: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

7. North America dPCR and qPCR Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 North America dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
  • 7.3 Reagents & Consumables
    • 7.3.1 Overview
    • 7.3.2 Reagents & Consumables: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Instruments
    • 7.4.1 Overview
    • 7.4.2 Instruments: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Software & Services
    • 7.5.1 Overview
    • 7.5.2 Software & Services: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

8. North America dPCR and qPCR Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 North America dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
  • 8.3 Research Application
    • 8.3.1 Overview
    • 8.3.2 Research Application: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Clinical Application
    • 8.4.1 Overview
    • 8.4.2 Clinical Application: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.4.2.1 North America dPCR and qPCR Market, by Clinical Application, 2020-2030 (US$ Million)
  • 8.5 Forensic Application
    • 8.5.1 Overview
    • 8.5.2 Forensic Application: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

9. North America dPCR and qPCR Market - Revenue and Forecast to 2030 - by End-User

  • 9.1 Overview
  • 9.2 North America dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
  • 9.3 Hospitals and Diagnostic Centers
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Diagnostic Centers: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Pharmaceutical and Biotechnology Companies
    • 9.4.1 Overview
    • 9.4.2 Pharmaceutical and Biotechnology Companies: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Research Laboratories and Academic Institutes
    • 9.5.1 Overview
    • 9.5.2 Research Laboratories and Academic Institutes: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Forensic Laboratories
    • 9.6.1 Overview
    • 9.6.2 Forensic Laboratories: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.7 Clinical Research Organizations
    • 9.7.1 Overview
    • 9.7.2 Clinical Research Organizations: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

10. North America dPCR and qPCR Market - Country Analysis

    • 10.1.1 North America dPCR and qPCR Market, by Country
      • 10.1.1.1 US
        • 10.1.1.1.1 US : North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.1.2 US: North America dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.1.3 US: North America dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.1.4 US: North America dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.1.4.1 US: North America dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 10.1.1.1.5 US: North America dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.1.2 Canada
        • 10.1.1.2.1 Canada: North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.2 Canada: North America dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.2.3 Canada: North America dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.2.4 Canada: North America dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.2.4.1 Canada: North America dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 10.1.1.2.5 Canada: North America dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.1.3 Mexico
        • 10.1.1.3.1 Mexico: North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.2 Mexico: North America dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.3.3 Mexico: North America dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.3.4 Mexico: North America dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.3.4.1 Mexico: North America dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 10.1.1.3.5 Mexico: North America dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)

11. dPCR and qPCR Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in North America dPCR and qPCR Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Thermo Fisher Scientific Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Takara Bio Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Qiagen NV
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Standard BioTools Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Lepu Medical Technology Beijing Co Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 F. Hoffmann-La Roche Ltd
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Bio-Rad Laboratories Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Agilent Technologies Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. North America dPCR and qPCR Market Segmentation
  • Table 2. North America dPCR and qPCR Market, by Clinical Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. US: North America dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. US: North America dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. US: North America dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. US: North America dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. US: North America dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Canada: North America dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Canada: North America dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Canada: North America dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Canada: North America dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Canada: North America dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Mexico: North America dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Mexico: North America dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Mexico: North America dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Mexico: North America dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Mexico: North America dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Recent Organic Growth Strategies in North America dPCR and qPCR Market
  • Table 19. Recent Inorganic Growth Strategies in the North America dPCR and qPCR Market
  • Table 20. Glossary of Terms, North America dPCR and qPCR Market

List Of Figures

  • Figure 1. North America dPCR and qPCR Market Segmentation, By Country
  • Figure 2. North America dPCR and qPCR Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. North America dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • Figure 6. Quantitative PCR: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Digital PCR: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. North America dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
  • Figure 9. Reagents & Consumables: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Instruments: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Software & Services: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. North America dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
  • Figure 13. Research Application: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Clinical Application: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Forensic Application: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. North America dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
  • Figure 17. Hospitals and Diagnostic Centers: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Pharmaceutical and Biotechnology Companies: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Research Laboratories and Academic Institutes: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Forensic Laboratories: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Clinical Research Organizations: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. North America: North America dPCR and qPCR Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 23. North America dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
  • Figure 24. US : North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Canada: North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Mexico: North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Growth Strategies in North America dPCR and qPCR Market